IARS1
Basic information
Region (hg38): 9:92210207-92293854
Previous symbols: [ "IARS" ]
Links
Phenotypes
GenCC
Source:
- growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy (Supportive), mode of inheritance: AR
- growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy (Strong), mode of inheritance: AR
- growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy | AR | Biochemical | Patients have been shown to have zinc deficiency (possibly related to chronic liver disease), and medical management (with zinc supplementation) has been shown to be beneficial | Biochemical; Gastrointestinal; Musculoskeletal; Neurologic | 27426735 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (265 variants)
- not_specified (182 variants)
- Growth_retardation,_intellectual_developmental_disorder,_hypotonia,_and_hepatopathy (34 variants)
- IARS1-related_disorder (20 variants)
- Global_developmental_delay (2 variants)
- Microcephaly (2 variants)
- Inborn_genetic_diseases (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IARS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000002161.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 72 | 79 | ||||
missense | 212 | 18 | 246 | |||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 13 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
Total | 21 | 10 | 213 | 90 | 15 |
Highest pathogenic variant AF is 0.0000557624
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IARS1 | protein_coding | protein_coding | ENST00000375643 | 33 | 83550 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.73e-21 | 0.999 | 125594 | 0 | 154 | 125748 | 0.000613 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.13 | 594 | 677 | 0.877 | 0.0000351 | 8281 |
Missense in Polyphen | 211 | 258.48 | 0.8163 | 3121 | ||
Synonymous | -0.831 | 258 | 242 | 1.07 | 0.0000126 | 2395 |
Loss of Function | 3.24 | 46 | 76.6 | 0.601 | 0.00000410 | 898 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00108 | 0.00108 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000876 | 0.000870 |
Finnish | 0.000370 | 0.000370 |
European (Non-Finnish) | 0.000644 | 0.000642 |
Middle Eastern | 0.000876 | 0.000870 |
South Asian | 0.000693 | 0.000686 |
Other | 0.000979 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the specific attachment of an amino acid to its cognate tRNA in a 2 step reaction: the amino acid (AA) is first activated by ATP to form AA-AMP and then transferred to the acceptor end of the tRNA. {ECO:0000269|PubMed:8052601}.;
- Pathway
- Aminoacyl-tRNA biosynthesis - Homo sapiens (human);Amino Acid metabolism;tRNA Aminoacylation;Translation;Metabolism of proteins;Metabolism of amino acids and derivatives;Metabolism;tRNA charging;Selenoamino acid metabolism;SeMet incorporation into proteins;Cytosolic tRNA aminoacylation
(Consensus)
Recessive Scores
- pRec
- 0.192
Intolerance Scores
- loftool
- 0.972
- rvis_EVS
- -1.07
- rvis_percentile_EVS
- 7.34
Haploinsufficiency Scores
- pHI
- 0.718
- hipred
- Y
- hipred_score
- 0.747
- ghis
- 0.598
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.997
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Iars
- Phenotype
Zebrafish Information Network
- Gene name
- iars
- Affected structure
- trunk vasculature
- Phenotype tag
- abnormal
- Phenotype quality
- increased amount
Gene ontology
- Biological process
- osteoblast differentiation;tRNA aminoacylation for protein translation;isoleucyl-tRNA aminoacylation;aminoacyl-tRNA metabolism involved in translational fidelity
- Cellular component
- cytoplasm;cytosol;membrane;aminoacyl-tRNA synthetase multienzyme complex;extracellular exosome
- Molecular function
- tRNA binding;aminoacyl-tRNA editing activity;isoleucine-tRNA ligase activity;protein binding;ATP binding;GTPase binding